203 related articles for article (PubMed ID: 15837117)
21. Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice.
Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
Pharmacol Biochem Behav; 2007 May; 87(1):48-55. PubMed ID: 17482247
[TBL] [Abstract][Full Text] [Related]
22. Role of melanin-concentrating hormone in the nucleus accumbens shell in rats behaviourally sensitized to methamphetamine.
Sun LL; Zhang Y; Liu JF; Wang J; Zhu WL; Zhao LY; Xue YX; Lu L; Shi J
Int J Neuropsychopharmacol; 2013 Sep; 16(8):1767-80. PubMed ID: 23449013
[TBL] [Abstract][Full Text] [Related]
23. Repeated amphetamine treatment increases phosphorylation of extracellular signal-regulated kinase, protein kinase B, and cyclase response element-binding protein in the rat striatum.
Shi X; McGinty JF
J Neurochem; 2007 Oct; 103(2):706-13. PubMed ID: 17635666
[TBL] [Abstract][Full Text] [Related]
24. The role of thioredoxin-1 in resisting methamphetamine-induced rewarding effect.
Huang M; Kong L; Yang L; Li X; Zhou X; Li Y; Bai J
Behav Brain Res; 2018 Jan; 337():280-286. PubMed ID: 28782589
[TBL] [Abstract][Full Text] [Related]
25. Effect of prenatal methadone on reinstated behavioral sensitization induced by methamphetamine in adolescent rats.
Wong CS; Lee YJ; Chiang YC; Fan LW; Ho IK; Tien LT
Behav Brain Res; 2014 Jan; 258():160-5. PubMed ID: 24157336
[TBL] [Abstract][Full Text] [Related]
26. Levo-tetrahydropalmatine attenuates the development and expression of methamphetamine-induced locomotor sensitization and the accompanying activation of ERK in the nucleus accumbens and caudate putamen in mice.
Zhao N; Chen Y; Zhu J; Wang L; Cao G; Dang Y; Yan C; Wang J; Chen T
Neuroscience; 2014 Jan; 258():101-10. PubMed ID: 24269936
[TBL] [Abstract][Full Text] [Related]
27. Effect of the protein kinase C inhibitor, staurosporine, on the high dose of methamphetamine-induced behavioral sensitization to dizocilpine (MK-801).
Fang YR; Abekawa T; Li XB; Wang ZC; Inoue T; Koyama T
Psychopharmacology (Berl); 2005 Jun; 180(1):100-6. PubMed ID: 15682296
[TBL] [Abstract][Full Text] [Related]
28. Reinstatement of methamphetamine conditioned place preference in nicotine-sensitized rats.
Berry JN; Neugebauer NM; Bardo MT
Behav Brain Res; 2012 Dec; 235(2):158-65. PubMed ID: 22884606
[TBL] [Abstract][Full Text] [Related]
29. Involvement of dorsal striatal α1-containing GABAA receptors in methamphetamine-associated rewarding memories.
Jiao DL; Liu Y; Long JD; Du J; Ju YY; Zan GY; Liu JG; Zhao M
Neuroscience; 2016 Apr; 320():230-8. PubMed ID: 26868969
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of vesicular glutamate transporters contributes to attenuate methamphetamine-induced conditioned place preference in rats.
He Z; Chen Y; Dong H; Su R; Gong Z; Yan L
Behav Brain Res; 2014 Jul; 267():1-5. PubMed ID: 24613241
[TBL] [Abstract][Full Text] [Related]
31. Development of sensitization to methamphetamine in offspring prenatally exposed to morphine, methadone and buprenorphine.
Chiang YC; Hung TW; Ho IK
Addict Biol; 2014 Jul; 19(4):676-86. PubMed ID: 23551991
[TBL] [Abstract][Full Text] [Related]
32. Effect of insulin deficiency on the rewarding properties of methamphetamine in streptozotocin-induced diabetic rats.
Bayat AH; Haghparast A
Pharmacol Biochem Behav; 2015 Jan; 128():8-13. PubMed ID: 25444864
[TBL] [Abstract][Full Text] [Related]
33. Place preference induced by nucleus accumbens amphetamine is impaired by antagonists of ERK or p38 MAP kinases in rats.
Gerdjikov TV; Ross GM; Beninger RJ
Behav Neurosci; 2004 Aug; 118(4):740-50. PubMed ID: 15301601
[TBL] [Abstract][Full Text] [Related]
34. Possible involvement of type 1 inositol 1,4,5-trisphosphate receptors up-regulated by dopamine D1 and D2 receptors in mouse nucleus accumbens neurons in the development of methamphetamine-induced place preference.
Kurokawa K; Mizuno K; Ohkuma S
Neuroscience; 2012 Dec; 227():22-9. PubMed ID: 23000618
[TBL] [Abstract][Full Text] [Related]
35. Thioredoxin-1 downregulation in the nucleus accumbens promotes methamphetamine-primed reinstatement in mice.
Huang M; Yan C; Yang X; Zhou X; Lv W; Guo N; Li Y; Bai J
Neuropharmacology; 2018 Sep; 139():117-123. PubMed ID: 29981334
[TBL] [Abstract][Full Text] [Related]
36. Roles of levo-tetrahydropalmatine in modulating methamphetamine reward behavior.
Su HL; Zhu J; Chen YJ; Zhao N; Han W; Dang YH; Xu M; Chen T
Physiol Behav; 2013 Jun; 118():195-200. PubMed ID: 23711566
[TBL] [Abstract][Full Text] [Related]
37. Implication of activated astrocytes in the development of drug dependence: differences between methamphetamine and morphine.
Narita M; Suzuki M; Kuzumaki N; Miyatake M; Suzuki T
Ann N Y Acad Sci; 2008 Oct; 1141():96-104. PubMed ID: 18991953
[TBL] [Abstract][Full Text] [Related]
38. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
39. The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats.
Nakayama H; Kitaichi K; Ito Y; Hashimoto K; Takagi K; Yokoi T; Takagi K; Ozaki N; Yamamoto T; Hasegawa T
Brain Res; 2007 Dec; 1184():260-9. PubMed ID: 17988657
[TBL] [Abstract][Full Text] [Related]
40. Ifenprodil Attenuates Methamphetamine-Induced Behavioral Sensitization and Activation of Ras-ERK-∆FosB Pathway in the Caudate Putamen.
Li L; Liu X; Qiao C; Chen G; Li T
Neurochem Res; 2016 Oct; 41(10):2636-2644. PubMed ID: 27339870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]